SecBot SecBot
EFFECT ·Filed Feb 27, 2026

GENB

Generate Biomedicines, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed8mo ago SEC9999999995-26-000677
IPO/offering going effective
Actionable Insight • Neutral

Monitor for imminent pricing announcement or prospectus supplement, which would indicate when shares will be offered and at what price. Be aware that shelf offerings can create a dilution overhang.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$12.65
T+0 close · Feb 27, 2026 · via day close
Latest settled
+5.45%
T+60 · $13.34
Vs SPY
−3.93%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 27 $12.65entry
  2. T+1 · 9mo ago −3.79%α −3.85% · $12.17
  3. T+5 · 9mo ago −11.38%α −9.40% · $11.21
  4. T+20 · 8mo ago −9.57%α −2.01% · $11.44
  5. T+60 · 6mo ago +5.45%α −3.93% · $13.34

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. This is an EFFECT filing for Generate Biomedicines, Inc. (GENB), indicating that a previously filed securities offering registration has become effective. The company can now proceed with the sale of securities, but details such as offering size, price, and timing are not available in the metadata.

Key Facts

  • Filing type is EFFECT, meaning a registration statement has become effective with the SEC.
  • Company: Generate Biomedicines, Inc. (GENB).
  • No document content available to determine offering specifics such as size, pricing, or use of proceeds.

Financial Impact

Not specified

dilutioncash

Risk Factors

  • Potential for near-term share dilution if a follow-on or shelf offering is executed.
  • Lack of transparency due to unavailable filing content limits ability to assess financial impact.

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

11 reports on GENB

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +14.28% at T+20 after the Oct 1, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Bearish 5/10 Entry $12.57 Now $10.49 +16.55% settles Dec 11
  2. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $12.57 Now $10.49 −16.55% settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $13.85 Now $10.49 −24.26% settles Dec 2
  4. Oct 29, 202618d ago 144 Neutral 2/10 Entry $14.46 Now $10.49 −27.46% settles Nov 30
  5. Oct 13, 20264w ago Press Release Bullish 6/10 Entry $12.52 to $13.49 Now $10.49 −16.21% ▲ +7.75% +9.02% vs SPY
  6. Oct 1, 20266w ago Press Release Bullish 5/10 Entry $13.80 to $15.77 Now $10.49 −23.99% ▲ +14.28% +13.57% vs SPY
  7. May 7, 202627w ago 8-K Bearish 6/10 Entry $13.59 to $12.91 Now $10.49 +22.81% ▲ +5.00% +8.14% vs SPY
  8. Mar 2, 202637w ago Insider Cluster Bullish 7/10 Entry $11.93 to $12.50 Now $10.49 −12.07% ▲ +4.78% +9.19% vs SPY
  9. Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $11.93 to $12.50 Now $10.49 −12.07% ▲ +4.78% +9.19% vs SPY
  10. Feb 27, 202637w ago 424B4 Bearish 7/10 Entry $12.17 to $11.51 Now $10.49 +13.80% ▲ +5.42% −2.52% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 27, 2026